Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal
Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal is a Välismaa äriühingu filiaal based in Tallinn, registry code 11716380, status: active. Main activity: Wholesale of medicines and other pharmacy goods. According to EMTA, turnover for Q3 2026 was €6 181 407 with 14 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 6.2 mn €above 98% of companiesindustry median 60 065 € · companies in the industry: 6 941
- Labour taxes per employee 8 071 €above 98% of companiesindustry median 2 104 € · companies in the industry: 4 194
Taxes and turnover
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 6 181 407 | 498 954 | 112 987 | 14 |
| Q2 2026 | 6 237 381 | 407 385 | 156 188 | 15 |
| Q1 2026 | 9 204 243 | 578 332 | 137 574 | 15 |
| Q4 2025 | 8 259 456 | 574 089 | 126 821 | 15 |
| Q3 2025 | 7 026 954 | 417 507 | 122 085 | 15 |
| Q2 2025 | 6 873 286 | 164 915 | 146 018 | 16 |
| Q1 2025 | 8 425 763 | 617 240 | 134 579 | 15 |
| Q4 2024 | 7 041 197 | 511 151 | 119 756 | 15 |
| Q3 2024 | 7 501 784 | 476 661 | 115 977 | 17 |
| Q2 2024 | 6 350 096 | 474 606 | 173 102 | 17 |
| Q1 2024 | 10 832 847 | 564 778 | 152 258 | 19 |
| Q4 2023 | 10 436 023 | 524 911 | 147 886 | 19 |
| Q3 2023 | 9 612 028 | 465 254 | 109 183 | 19 |
| Q2 2023 | 8 942 215 | 518 117 | 211 027 | 19 |
| Q1 2023 | 9 790 504 | 469 496 | 126 726 | 19 |
| Q4 2022 | 8 900 644 | 435 012 | 135 348 | 19 |
| Q3 2022 | 8 697 998 | 402 786 | 102 291 | 19 |
| Q2 2022 | 8 557 982 | 456 848 | 177 693 | 20 |
| Q1 2022 | 9 528 758 | 444 032 | 130 033 | 20 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Employees |
|---|---|---|
| 2025 | — | 0 |
| 2024 | — | 0 |
| 2023 | — | 0 |
| 2022 | — | 0 |
| 2021 | — | 0 |
| 2020 | — | 0 |
| 2019 | — | 0 |
| 2018 | — | 0 |
| 2017 | — | 0 |
| 2016 | — | 0 |
| 2015 | — | 0 |
| 2014 | — | 0 |
| 2013 | — | 0 |
| 2012 | — | 0 |
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 25 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 6 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 25 Aug 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 3 Jul 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 30 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 7 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 11 Jun 2020 | Company’s own | e-Äriregister |
Board
- Natalja NešumajevaProcurator · since 10 Sep 2024
- Elisabeth TomaschkoStatutory representative of the company · since 17 Sep 2009
- Georg VanaStatutory representative of the company · since 17 Sep 2009
- Boehringer Ingelheim RCV GmbHStatutory representative of the company · since 17 Sep 2009
- Christian EckermannStatutory representative of the company · since 29 Apr 2014
- Darryl McConnellStatutory representative of the company · since 27 Sep 2016
- Christine RauchStatutory representative of the company · since 11 Nov 2019
- Jochen HeberleStatutory representative of the company · since 11 Nov 2019
- Michael KraftStatutory representative of the company · since 11 Nov 2019
- Mirela Liliana CiocirlanStatutory representative of the company · since 11 Nov 2019
- Vincent BouéStatutory representative of the company · since 11 Nov 2019
- Holger OttlebenStatutory representative of the company · since 18 Jan 2022
- Philipp von HülsenStatutory representative of the company · since 18 Jan 2022
- Rainer ZelbacherStatutory representative of the company · since 18 Jan 2022
- Lina ValiulienėBranch manager · since 7 Sep 2021
- Marta Ines Carrera RobertBranch manager · since 3 Oct 2025
Right of representation
Any branch manager may represent the branch in all transactions.
Owners
No owner information.
Activities (EMTAK)
- 46461Wholesale of medicines and other pharmacy goods Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10133828 / 27 3 Oct 2025 |
Amendment entry | In force 3 Oct 2025 |
||
| Ä 10133828 / 26 3 Jun 2025 |
Amendment entry | In force 3 Jun 2025 |
||
| Ä 10133828 / 25 18 Sep 2024 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 18 Sep 2024 |
||
| Ä 10133828 / 24 10 Sep 2024 |
Amendment entry | In force 10 Sep 2024 |
||
| Ä 10133828 / 23 16 Jan 2024 |
Amendment entry | In force 16 Jan 2024 |
||
| Ä 10133828 / 22 21 Apr 2022 |
Amendment entry | In force 21 Apr 2022 |
||
| Ä 10133828 / 21 18 Jan 2022 |
Amendment entry | In force 18 Jan 2022 |
||
| Ä 10133828 / 20 28 Dec 2021 |
Amendment entry | In force 28 Dec 2021 |
||
| Ä 10133828 / 19 21 Dec 2021 |
Amendment entry | In force 21 Dec 2021 |
||
| Ä 10133828 / 18 22 Sep 2021 |
Amendment entry | In force 22 Sep 2021 |
||
| Ä 10133828 / 17 7 Sep 2021 |
Amendment entry | In force 7 Sep 2021 |
||
| Ä 10133828 / M3 2 Sep 2021 |
Ruling to eliminate deficiencies | 2 Oct 2021 | Deficiencies eliminated 7 Sep 2021 |
|
| Ä 10133828 / 16 9 Dec 2019 |
Amendment entry | In force 9 Dec 2019 |
||
| Ä 10133828 / 15 11 Nov 2019 |
Amendment entry | In force 11 Nov 2019 |
||
| Ä 10133828 / 14 1 Oct 2019 |
Amendment entry | In force 1 Oct 2019 |
||
| Ä 10133828 / 13 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10133828 / 12 1 Dec 2017 |
Amendment entry | In force 1 Dec 2017 |
||
| Ä 10133828 / 11 23 Jan 2017 |
Amendment entry | In force 23 Jan 2017 |
||
| Ä 10133828 / 9 27 Sep 2016 |
Amendment entry | In force 27 Sep 2016 |
||
| Ä 10133828 / 10 27 Sep 2016 |
Amendment entry | In force 27 Sep 2016 |
||
| Ä 10133828 / 8 31 Aug 2016 |
Amendment entry | In force 31 Aug 2016 |
||
| Ä 10133828 / 7 18 Aug 2016 |
Amendment entry | In force 18 Aug 2016 |
||
| Ä 10133828 / 6 18 Sep 2014 |
Amendment entry | In force 18 Sep 2014 |
||
| Ä 10133828 / 5 29 Apr 2014 |
Amendment entry | In force 29 Apr 2014 |
||
| Ä 10133828 / M2 17 Apr 2014 |
Ruling to eliminate deficiencies | 2 May 2014 | In force 17 Apr 2014 |
|
| Ä 10133828 / 4 12 Mar 2014 |
Amendment entry | In force 12 Mar 2014 |
||
| Ä 10133828 / M1 19 Feb 2014 |
Ruling to eliminate deficiencies | 21 Mar 2014 | Deficiencies eliminated 11 Mar 2014 |
|
| Ä 10133828 / 3 25 Jul 2011 |
Amendment entry | In force 25 Jul 2011 |
||
| Ä 10133828 / 2 9 Jun 2011 |
Amendment entry | In force 9 Jun 2011 |
||
| Ä 133828 17 Sep 2009 |
First entry | In force 17 Sep 2009 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data